Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT01331694 · COMPLETED

Trial details

NCT number: NCT01331694
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2009-07-01
Primary completion: 2010-05-01
Enrollment: 76130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.